Page last updated: 2024-11-01

niclosamide and Adrenocortical Carcinoma

niclosamide has been researched along with Adrenocortical Carcinoma in 1 studies

Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.

Adrenocortical Carcinoma: A malignant neoplasm of the ADRENAL CORTEX. Adrenocortical carcinomas are unencapsulated anaplastic (ANAPLASIA) masses sometimes exceeding 20 cm or 200 g. They are more likely to be functional than nonfunctional, and produce ADRENAL CORTEX HORMONES that may result in hypercortisolism (CUSHING SYNDROME); HYPERALDOSTERONISM; and/or VIRILISM.

Research Excerpts

ExcerptRelevanceReference

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Satoh, K1
Zhang, L1
Zhang, Y1
Chelluri, R1
Boufraqech, M1
Nilubol, N1
Patel, D1
Shen, M1
Kebebew, E1

Other Studies

1 other study available for niclosamide and Adrenocortical Carcinoma

ArticleYear
Identification of Niclosamide as a Novel Anticancer Agent for Adrenocortical Carcinoma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2016, 07-15, Volume: 22, Issue:14

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Animals; Antineoplastic Agents; Apoptosis; beta

2016